#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary spastic paraplegia Biliary cancer metastatic Heavy menstrual bleeding Breast cancer Behcet's syndrome Mantle cell lymphoma refractory Kearns-Sayre syndrome Acute lymphocytic leukaemia Progressive supranuclear palsy Haemophilia B with anti factor IX Chronic lymphocytic leukaemia recurrent Iron overload Thymic carcinoma Immune-mediated enterocolitis Pancreatic carcinoma metastatic More trials…

    Learn about Rare Diseases

    SAPHO syndrome – Basic Information Acquired haemophilia – Trials in Disease Mantle cell lymphoma stage II – Treatment Anaplastic thyroid cancer Congenital hypotransferrinaemia – Basic Information Antisynthetase syndrome – Diagnostics Leiomyosarcoma – Life with Disease Progressive supranuclear palsy – Diagnostics Synovial sarcoma metastatic – Basic Information Hypereosinophilic syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dsimc Bendamustine Hydrochloride Acetylcholine Chloride Sildenafil F125/10 ASP3082 Dexamethasone Acetate Phosphocreatine Sodium TAZAROTENE Tozorakimab Prilocaine Candesartan THEOPHYLLINE ANHYDROUS Atomoxetine Cenobamate Foscarnet Sodium Oxybate 18F-Psma-1007 Gemlapodect AMG 732 More therapies…

    Learn about Your Condition

    Brain stem glioma Endocarditis enterococcal Haemorrhagic stroke Status epilepticus Congenital aplastic anaemia Skin angiosarcoma Osteogenesis imperfecta Iron deficiency Laparotomy Pleural mesothelioma malignant Hydrocephalus Urticaria chronic Malignant glioma Hip fracture Angiosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut de Cancérologie Hématologie Universitaire…

Institut de Cancérologie Hématologie Universitaire de Saint Etienne (iCHUSE)

Avenue Albert Raimond, Saint Priest En Jarez, 42270, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study of drug combinations including cisplatin, carboplatin, doxorubicin, fluorouracil, vincristine, etoposide, irinotecan, gemcitabine, oxaliplatin and sorafenib for children with hepatoblastoma or hepatocellular carcinoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Sorafenib
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia France Germany Ireland +4

  • Study Comparing Doravirine/Lamivudine and Dolutegravir/Lamivudine for HIV Patients with Controlled Viral Load on Three-Drug Regimens

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dolutegravir
    • Doravirine
    • Lamivudine
    France

  • Study on Botulinum Toxin Type A for Preventing Shoulder Deformity in Infants with Brachial Plexus Palsy

    Recruiting

    3 1 1
    Investigated Drugs:
    • Botulinum Toxin Type A
    • Sodium Chloride
    France

  • Study Comparing Rifabutin and Rifampicin for Adults with Staphylococcal Prosthetic Joint Infection Using DAIR Strategy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Rifabutin
    • Rifampicin
    France

  • Study on the Effectiveness and Safety of Vedolizumab and Upadacitinib in Adults with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Vedolizumab
    • Upadacitinib
    Austria Belgium Croatia Czechia Denmark France +12

  • Comparison of Oxytocin versus Prostaglandins (Dinoprostone and Misoprostol) for Labor Induction in Women with Unfavorable Cervix After Initial Cervical Ripening

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dinoprostone
    • Misoprostol
    • Oxytocin
    France

  • Study on Early Treatment of Plaque Psoriasis with Bimekizumab and Clobetasol Propionate for Patients with Chronic Inflammation

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Bimekizumab
    • Clobetasol Propionate
    France

  • Study Comparing FOLFOX (Oxaliplatin, Fluorouracil, Calcium Folinate) to Gemcitabine for Patients with Metastatic Pancreatic Cancer Not Suitable for FOLFIRINOX

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Adenocarcinoma pancreas
    Investigated Drugs:
    • Calcium Folinate
    • Fluorouracil
    • Gemcitabine Hydrochloride
    France

  • Study Comparing Continuous and Fixed Duration Therapy with Daratumumab, Lenalidomide, and Dexamethasone for Patients with Relapsed Multiple Myeloma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma recurrent
    Investigated Drugs:
    • Betamethasone Sodium Phosphate
    • Daratumumab
    France

  • Study on Elacestrant and Everolimus for Patients with Advanced ER+/HER2- Breast Cancer Resistant to Endocrine Therapy and CDK4/6 Inhibitors

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Elacestrant
    • Leuprorelin Acetate
    • Triptorelin Acetate
    Austria Czechia France Germany Greece Italy +1
Previous Page
1 … 8 9 10 11 12 … 46
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!